Oviduct Glycoprotein 1 (OVGP1) Diagnoses Polycystic Ovary Syndrome (PCOS) Based on Machine Learning Algorithms.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed, 3 syntheses or guidelines pooled it.

1. Machine learning and deep learning for diagnosis of Polyendocrine Metabolic Ovarian Syndrome: systematic review and meta-analysis.Frontiers in endocrinology · 2026
   Pooled it
2. Artificial intelligence in polycystic ovary syndrome: a systematic review of diagnostic and predictive applications.BMC medical informatics and decision making · 2025
   Pooled it
3. Artificial intelligence in polycystic ovarian syndrome management: past, present, and future.La Radiologia medica · 2025
   Pooled it
4. AutoPCOS: a stepwise multimodal intelligent framework for polycystic ovary syndrome risk stratification and diagnostic support.Frontiers in endocrinology · 2026
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

6 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.